• BIVDA members area

Members' Press Releases

From the monthly archives: June, 2017

We are pleased to present below all posts archived in 'June, 2017'. If you still can't find what you are looking for, try using the search box.

DiaSorin and Tecan to collaborate in new platform development

DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform. The new platform will be used in combination with the DiaSorin Liaison® MDX PCR system to provide the customer with a complete sample to result system for molecular diagnostics.

Read the rest of entry »

Cytox raises £2.6m led by Catapult Ventures to launch predictive testing service for Alzheimer’s disease

Investment will help commercialize Cytox’s services for testing for Alzheimer’s disease and grow Cytox as a leader in this area

15 June 2017, Oxford & Alderley Park, UK.  Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, has announced that it has raised £2.6m (approx $3.3m) to fund the commercial launch and international roll out of its comprehensive testing service. The funding round was led by the GM&C Life Sciences Fund, managed by Catapult Ventures, alongside existing and new investors, including Perivoli Innovations, The Rainbow Seed Fund, The University of Oxford and private investors.

Read the rest of entry »

Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC

Cardiff, UK – 21st June 2017 – EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab-based HPLC system for the measurement of glycated hemoglobin (HbA1c). Recently published in Practical Laboratory Medicine [1], the study undertaken by the Diabetes Research Unit Cymru, Swansea University, UK, also observed that under the correct circumstances using WHO guidelines Quo-Test is appropriate for the diagnosis of Type 2 diabetes.

Read the rest of entry »

The TOPRA Annual Symposium

The TOPRA Annual Symposium is the largest forum for European regulatory professionals to meet up, discuss current regulatory issues and debate future plans for regulation.

Read the rest of entry »

SpeeDx and Cepheid Announce Partnership on European Distribution

SYDNEY, AUSTRALIA -- 05/06/17 -- SpeeDx Pty, Ltd. today announced an agreement with Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the UK, will increase coverage for the market-leading ResistancePlus MG test, the first CE-IVD test for Mycoplasma genitalium to combine detection with testing for azithromycin resistance.

Read the rest of entry »

MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer

Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated Idylla™ platform

London (UK) / Mechelen (Belgium), 7 June 2017 – MRC Technology (‘MRCT’), a medical research charity, and Biocartis Group NV (‘Biocartis’ or the ‘Company’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announced a partnership to develop selected molecular diagnostic tests for use on Biocartis’ fully automated Idylla™ platform. MRCT aims to move promising medical research forward into patient treatments and diagnostics and has been involved in helping deliver a number of therapies including Keytruda® (pembrolizumab, marketed by MSD) which is an important immunotherapy treatment for various cancers.

Read the rest of entry »

Hands-on lateral flow test development workshop

BBI Solutions, in partnership with Merck and Kinematic Automation, is hosting a lateral flow seminar designed to provide a practical insight into lateral flow test development. Taking place from the 6th to the 8th of June at the Fota Island Resort in Cork, Ireland, this event is aimed at industry professionals, and will cover various aspects of assay development and commercialisation, as well as offering a hands-on experience in test design.

Read the rest of entry »

BBI Solutions Increases Capacity for Cell Culture Native Human Transferrin Production

BBI Solutions (BBI) has invested into its facilities and resource in order to increase the capacity of cell culture transferrin production by up to 40%.

Read the rest of entry »

Archive